Clinical Trials Directory

Trials / Completed

CompletedNCT04760678

Febrile Illness in Kinshasa and Kimpese

Clinical Aspects, Severity, Management and Outcome of Febrile Illnesses in the Democratic Republic Congo (DRC).

Status
Completed
Phase
Study type
Observational
Enrollment
1,046 (actual)
Sponsor
Institute of Tropical Medicine, Belgium · Academic / Other
Sex
All
Age
2 Months
Healthy volunteers
Not accepted

Summary

This is a bi-centric prospective observational cohort study of adults and children presenting to the emergency room or outpatient department with community febrile illness (with or without signs of focalization) in 2 clinical sites (hospitals) in the DRC. The study will describe the epidemiology, clinical aspects, severity, management and outcome of febrile illnesses using data collected during routine diagnostic and therapeutic procedures. Each patient will be followed for 21 days. The follow-up will include * Daily visits for hospitalized patients, * Telephone calls (or study center visit or home visit) on days 7, 14 and 21 for outpatients and discharged patients. The study has been amended (EC UZA approval in June 2021) to perform a set of laboratory analyses in the partners institutions and at the ITM. We aim as a new primary objective at describing the profile of different biomarkers (C-reactive protein and white blood cell count with differentiation) in participants enrolled with febrile illness, and as secondary objectives to correlate them with outcome (assessed at day 21) and with several etiological diagnoses, especially malaria (as assessed by rapid diagnostic test and blood smear). The purpose is to investigate the potential diagnostic and prognostic value of these biomarkers which are increasingly available at the point-of-care.

Conditions

Interventions

TypeNameDescription
OTHERObservational studyNo intervention (observational study in human participants)

Timeline

Start date
2021-03-01
Primary completion
2023-09-18
Completion
2023-09-18
First posted
2021-02-18
Last updated
2025-03-06
Results posted
2025-03-06

Locations

2 sites across 1 country: Democratic Republic of the Congo

Source: ClinicalTrials.gov record NCT04760678. Inclusion in this directory is not an endorsement.